Global Data Archives - Express Pharma

Pharma CMO M&A activity shifts focus to scaling in 2023: GlobalData

GLP-1R agonists’ type 2 diabetes and obesity market to reach $125 billion in 7MM by 2033: GlobalData

Chinese companies lead ADC development pipeline: GlobalData

Chinese regulators focus on homegrown COVID-19 therapies to tackle new variants: GlobalData

Biologic sales to pass innovative small molecules in next five years: GlobalData

Three big-ticket deals contributed 69 per cent of total deal value in November 2020

Three major deals contributed 74 per cent of deal value in August 2020

Healthcare industry reports 95 deals worth $4.9 billion in July 2020

Small market cap companies more dependent on COVID-19 pipeline drug: GlobalData

Pharma industry witnesses 50 deals worth $3 billion in April 2020